About Decipher Biosciences, Inc. (adapted from Decipher Biosciences, Inc. prospectus):
They are a commercial-stage precision oncology company committed to improving patient care, with a focus in urologic oncology specific to prostate and bladder cancers.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.